Risk of Breast Cancer Recurrence Reduced With Letrozole, International Study Finds
Novel Antifungal Agent Highly Active Against Esophageal Candidiasis
Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia
Cholesterol-Lowering Drugs May Prevent Breast Cancer
Acceptance Of Sentinel Node Biopsy Is Growing, Study Finds
NCCN Updates Breast Cancer Guidelines for Patients
Lung Cancer Clinical Trials Cost-Effective Alternative
Letters From Ovarian Cancer Survivors Shed Light On Their Psychological Distress
New Drug Reduces Nausea and Vomiting
Clinical Trials Approved By NCI
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Long-awaited results from first phase III trial of a RAS inhibitor in pancreatic cancer shows that daraxonrasib doubles median OS
PanCAN’s Berkenblit: “It’s here. This is a tipping point, and we’ve tipped. And this is just the beginning.” - Protecting the cure: Why the future of radiation oncology must be precision-guided
- Letai: Perceptions aside, money is flowing and the cancer research infrastructure is sturdy
NCI expects record-breaking spending on extramural research - Chernobyl: a 35 year follow up on long-term health effects
- Cancer AI Alliance announces first wave of pilot projects
